The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Wasman Jane since year 2005.
The trader's CIK number is 1352455.
At the time of this reporting, Wasman Jane is the Exec VP, General Counsel & Sec of Acorda Therapeutics Inc .
(stock ticker symbol ACOR).
See this page for all insider trading activities at Acorda Therapeutics Inc .
Stock purchases, sales, and option exercises reported by insider Wasman Jane since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-06-11
ACOR
Acorda Therapeutics Inc
Option Exercise
3,500
5.85
20,475
2008-06-11
ACOR
Acorda Therapeutics Inc
Sale
3,500
31.61
110,623
2008-05-12
ACOR
Acorda Therapeutics Inc
Sale
2,425
19.16
46,458
2008-02-11
ACOR
Acorda Therapeutics Inc
Sale
2,425
22.99
55,754
2008-01-23
ACOR
Acorda Therapeutics Inc
Sale
2,425
22.66
54,953
2007-12-21
ACOR
Acorda Therapeutics Inc
Sale
2,425
20.56
49,851
2007-11-12
ACOR
Acorda Therapeutics Inc
Sale
2,425
18.76
45,499
2007-10-23
ACOR
Acorda Therapeutics Inc
Sale
2,425
20.13
48,818
2007-09-26
ACOR
Acorda Therapeutics Inc
Sale
2,425
18.79
45,563
2007-08-10
ACOR
Acorda Therapeutics Inc
Sale
2,425
16.99
41,205
2007-05-10
ACOR
Acorda Therapeutics Inc
Sale
2,600
24.76
64,370
2007-02-12
ACOR
Acorda Therapeutics Inc
Sale
2,600
21.46
55,798
2006-11-10
ACOR
Acorda Therapeutics Inc
Sale
4,851
15.21
73,765
2006-11-07
ACOR
Acorda Therapeutics Inc
Sale
8,200
15.75
129,150
2006-11-07
ACOR
Acorda Therapeutics Inc
Sale
6,700
15.22
102,005
2006-11-07
ACOR
Acorda Therapeutics Inc
Sale
100
14.89
1,489
2006-11-06
ACOR
Acorda Therapeutics Inc
Sale
22,000
16.06
353,246
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Wasman Jane
(Exec VP, General Counsel & Sec of Acorda Therapeutics Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
